HE4--a novel promising serum marker in the diagnosis of ovarian carcinoma

Biomarkers have a wide range of applications in the management of several cancers. To date serum markers have been the most extensively used biomarkers in everyday practice but few markers are elevated in preclinical or premalignant disease, limiting their importance for estimating risk or for scree...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of gynaecological oncology Vol. 32; no. 6; p. 605
Main Authors Langmár, Z, Németh, M, Vleskó, G, Király, M, Hornyák, L, Bösze, P
Format Journal Article
LanguageEnglish
Published Italy 2011
Subjects
Online AccessGet more information

Cover

Loading…